Published in Methods Enzymol on January 01, 2003
HIV-1 Nef membrane association depends on charge, curvature, composition and sequence. Nat Chem Biol (2009) 1.29
Bending and puncturing the influenza lipid envelope. Biophys J (2011) 0.94
Constant pressure-controlled extrusion method for the preparation of Nano-sized lipid vesicles. J Vis Exp (2012) 0.90
The N-terminal domain tethers the voltage-gated calcium channel β2e-subunit to the plasma membrane via electrostatic and hydrophobic interactions. J Biol Chem (2014) 0.88
Effect of envelope proteins on the mechanical properties of influenza virus. J Biol Chem (2012) 0.87
A simple guide to biochemical approaches for analyzing protein-lipid interactions. Mol Biol Cell (2012) 0.85
Cytochrome c-lipid interactions: new insights from resonance energy transfer. Biophys J (2010) 0.83
Changes in Listeria monocytogenes membrane fluidity in response to temperature stress. Appl Environ Microbiol (2007) 0.82
The fusogenic lipid phosphatidic acid promotes the biogenesis of mitochondrial outer membrane protein Ugo1. J Cell Biol (2015) 0.80
Unravelling the complex drug-drug interactions of the cardiovascular drugs, verapamil and digoxin, with P-glycoprotein. Biosci Rep (2016) 0.77
Polymeric Materials for Gene Delivery and DNA Vaccination. Adv Mater (2008) 0.76
Förster resonance energy transfer evidence for lysozyme oligomerization in lipid environment. J Phys Chem B (2010) 0.75
Morphological changes of supported lipid bilayers induced by lysozyme: planar domain formation vs. multilayer stacking. Colloids Surf B Biointerfaces (2010) 0.75
Quantified CSF antibody reactivity against myelin in multiple sclerosis. Ann Clin Transl Neurol (2015) 0.75
Comparison of Extruded and Sonicated Vesicles for Planar Bilayer Self-Assembly. Materials (Basel) (2013) 0.75
Rational design of cationic lipids for siRNA delivery. Nat Biotechnol (2010) 4.97
Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms. Mol Ther (2010) 3.26
Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo. Angew Chem Int Ed Engl (2012) 1.87
Immunogenicity and rapid blood clearance of liposomes containing polyethylene glycol-lipid conjugates and nucleic Acid. J Pharmacol Exp Ther (2004) 1.23
Influence of cationic lipid composition on gene silencing properties of lipid nanoparticle formulations of siRNA in antigen-presenting cells. Mol Ther (2011) 1.23
Biodegradable lipids enabling rapidly eliminated lipid nanoparticles for systemic delivery of RNAi therapeutics. Mol Ther (2013) 1.11
Lipid Nanoparticles Containing siRNA Synthesized by Microfluidic Mixing Exhibit an Electron-Dense Nanostructured Core. J Phys Chem C Nanomater Interfaces (2012) 0.93
Optimization and characterization of a sphingomyelin/cholesterol liposome formulation of vinorelbine with promising antitumor activity. J Pharm Sci (2005) 0.92
Expression and function of ATIP/MTUS1 in human prostate cancer cell lines. Prostate (2010) 0.89
The combination of stabilized plasmid lipid particles and lipid nanoparticle encapsulated CpG containing oligodeoxynucleotides as a systemic genetic vaccine. J Gene Med (2009) 0.78
The effect of bilayer and hexagonal H(II) phase lipid films on transepidermal water loss. Exp Dermatol (2006) 0.78
Appearance of angiotensin II expression in non-basal epithelial cells is an early feature of malignant change in human prostate. Cancer Detect Prev (2007) 0.78